Editorial: Clinical phytopharmacology.
作者信息
Willcox Merlin L, Tai Chi-Jung, Chattopadhyay Kaushik, Hu Xiao-Yang, Heinrich Michael
机构信息
Primary Care Research Centre, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Department of Family Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
出版信息
Front Pharmacol. 2024 Jan 15;14:1353483. doi: 10.3389/fphar.2023.1353483. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Clinical phytopharmacology.
Front Pharmacol. 2024 Jan 15;14:1353483. doi: 10.3389/fphar.2023.1353483. eCollection 2023.
2
From the CONSORT to the ConPhyMP statement and beyond-how to ascertain best practice.
Front Pharmacol. 2023 Dec 11;14:1338710. doi: 10.3389/fphar.2023.1338710. eCollection 2023.
3
Impact of the Consolidated Standards of Reporting Trials (CONSORT) checklist on reporting of randomized clinical trials in traditional Chinese medicine.
J Evid Based Med. 2015 Nov;8(4):192-208. doi: 10.1111/jebm.12173.
4
Endorsement of the CONSORT statement by Chinese journals of Traditional Chinese Medicine: a survey of journal editors and review of journals' instructions for authors.
Acupunct Med. 2016 Jun;34(3):178-83. doi: 10.1136/acupmed-2015-010870. Epub 2016 Jan 6.
5
Endorsement for improving the quality of reports on randomized controlled trials of traditional medicine journals in Korea: a systematic review.
Trials. 2014 Nov 5;15:429. doi: 10.1186/1745-6215-15-429.
6
Assessment of the reporting quality of randomized controlled trials on treatment of coronary heart disease with traditional chinese medicine from the chinese journal of integrated traditional and Western medicine: a systematic review.
PLoS One. 2014 Jan 28;9(1):e86360. doi: 10.1371/journal.pone.0086360. eCollection 2014.
7
Reporting quality of randomized controlled trials of angina pectoris with integrated traditional Chinese and western medicine interventions: a cross-sectional study.
BMC Med Res Methodol. 2023 May 23;23(1):124. doi: 10.1186/s12874-023-01953-1.
8
Endorsement of CONSORT by Chinese medical journals: a survey of "instruction to authors".
Chin J Integr Med. 2014 Jul;20(7):510-5. doi: 10.1007/s11655-014-1865-8. Epub 2014 Jun 28.
9
Ethnobotany and phytopharmacology of Pinus roxburghii Sargent: a plant review.
J Integr Med. 2013 Nov;11(6):371-6. doi: 10.3736/jintegrmed2013053.
10
Assessment of the reporting quality of randomized controlled trials on the treatment of diabetes mellitus with traditional chinese medicine: a systematic review.
PLoS One. 2013 Jul 24;8(7):e70586. doi: 10.1371/journal.pone.0070586. Print 2013.
引用本文的文献
1
Isorhamnetin: Reviewing Recent Developments in Anticancer Mechanisms and Nanoformulation-Driven Delivery.
Int J Mol Sci. 2025 Jul 30;26(15):7381. doi: 10.3390/ijms26157381.
2
The Introduction of the Global Traditional, Complementary, and Integrative Healthcare (TCIH) Research Agenda on Antimicrobial Resistance and Its Added Value to the WHO and the WHO/FAO/UNEP/WOAH 2023 Research Agendas on Antimicrobial Resistance.
Antibiotics (Basel). 2025 Jan 17;14(1):102. doi: 10.3390/antibiotics14010102.
3
Isorhamnetin: what is the evidence for its antitumor potential and beyond?
Front Pharmacol. 2024 Apr 8;15:1309178. doi: 10.3389/fphar.2024.1309178. eCollection 2024.
本文引用的文献
1
Use of herbal medicines for the management of type 2 diabetes: A systematic review of qualitative studies.
Complement Ther Clin Pract. 2023 Nov;53:101808. doi: 10.1016/j.ctcp.2023.101808. Epub 2023 Oct 28.
2
Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial.
Front Pharmacol. 2023 Sep 25;14:1221905. doi: 10.3389/fphar.2023.1221905. eCollection 2023.
3
Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners.
Front Med (Lausanne). 2023 Jan 30;10:1043715. doi: 10.3389/fmed.2023.1043715. eCollection 2023.
4
Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research-The ConPhyMP-Guidelines.
Front Pharmacol. 2022 Sep 13;13:953205. doi: 10.3389/fphar.2022.953205. eCollection 2022.
5
Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Front Pharmacol. 2022 Jul 4;13:923395. doi: 10.3389/fphar.2022.923395. eCollection 2022.
6
Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis.
Front Pharmacol. 2022 Jun 8;13:821810. doi: 10.3389/fphar.2022.821810. eCollection 2022.
7
Bupleuri radix for Acute Uncomplicated Respiratory Tract Infection: A Systematic Review of Randomized Controlled Trials.
Front Pharmacol. 2022 Feb 4;12:787084. doi: 10.3389/fphar.2021.787084. eCollection 2021.
8
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
9
Effectiveness of Medicinal Plants for Glycaemic Control in Type 2 Diabetes: An Overview of Meta-Analyses of Clinical Trials.
Front Pharmacol. 2021 Nov 26;12:777561. doi: 10.3389/fphar.2021.777561. eCollection 2021.
10
The Chang Gung Research Database: Multi-institutional real-world data source for traditional Chinese medicine in Taiwan.
Pharmacoepidemiol Drug Saf. 2021 May;30(5):652-660. doi: 10.1002/pds.5208. Epub 2021 Mar 5.
Zotero 插件